Investors making a wish list of stocks to watch should take a look at Gilead Sciences, Inc. (NASDAQ:GILD). The stock is offering a price-to-sales ratio of 3.41. This situation may create an opportunity where long term players can win with either market bounce, or when long-term value is realized. The broad Biotechnology industry has an average P/S ratio of 96.51, which is significantly worse than the sector’s 5.42. In the past 13-year record, this ratio went down as low as 2.95 and as high as 12.5. Also, it is up from 76% of the total 706 rivals across the globe. GILD traded at an unexpectedly low level on 11/28/2017 when the stock experienced a 1.24% gain to a closing price of $72.59. The company saw 5.85 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 9.57 million shares a day, this signifies a pretty significant change over the norm. Analysts are speculating a 32.25% move, based on the high target price ($96) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $85.17 price target, but the stock is already up 13.85% from its recent lows. However, the stock is trading at -15.85% versus recent highs ($86.2666). Analysts believe that we could see stock price minimum in the $65 range (lowest target price), allowing for another -10.46% drop from its current position. Leading up to this report, we have seen a -5.81% fall in the stock price over the last 30 days and a -4.16% decline over the past 3 months. Overall, the share price is up 1.37% so far this year. Additionally, GILD had a day price range of $71.4 to $72.68. Heading into the stock price potential, Gilead Sciences, Inc. needs to grow just 17.1% to cross its median price target of $85. In order to determine directional movement, the 50-day and 200-day moving averages for Gilead Sciences, Inc. (NASDAQ:GILD) are $76.26 and $74.03. Given that liquidity is king in short-term, GILD is a stock with 1.31 billion shares outstanding that normally trades 1.51% of its float. The stock price recently experienced a 5-day gain of 0.64% with 1.39 average true range (ATR). GILD has a beta of 1.16 and RSI is 39.86. Investors also need to beware of the The Procter & Gamble Company (NYSE:PG) valuations. The stock trades on a P/S of 3.46, which suggests that the shares are attractive compared with peers. The broad Personal Products industry has an average P/S ratio of 7.63, which is significantly worse than the sector’s 6.21. In the past 13-year record, this ratio went down as low as 1.83 and as high as 3.91. Also, it is down from 84% of the total 1560 rivals across the globe. The Procter & Gamble Company by far traveled 10.13% versus a 1-year low price of $81.18. The share price was last seen 0.49% higher, reaching at $89.4 on 11/28/2017. At recent session, the prices were hovering between $88.91 and $89.52. This company shares are 3.27% off its target price of $92.32 and the current market capitalization stands at $226.5B. The recent change has given its price a -0.57% deficit over SMA 50 and -5.57% deficit over its 52-week high. The stock witnessed 2.71% gains, -3.16% declines and 1.49% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found PG’s volatility during a week at 0.94% and during a month it has been found around 0.99%. The Procter & Gamble Company (PG) exchanged hands at an unexpectedly low level of 4.81 million shares over the course of the day. Noting its average daily volume at 6.9 million shares each day over the month, this signifies a pretty significant change over the norm. The market experts are predicting a 17.45% rally, based on the high target price ($105) for The Procter & Gamble Company shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $80 range (lowest target price). If faced, it would be a -10.51% drop from its current position. Overall, the share price is up 6.33% year to date.